Cargando…
Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction
Introduction: Colorectal cancer (CRC) is the fourth most common cancer worldwide, with high morbidity and mortality rates. In recent years, high-fat diet has been shown to increase CRC morbidity, highlighting the possibility of the application of hypolipidemic drugs for CRC treatment. In this study,...
Autores principales: | Zheng, Yuanyuan, Yang, Wenjuan, Jia, Yewei, Ji, Jie, Wu, Liwei, Feng, Jiao, Li, Yan, Cheng, Ziqi, Zhang, Jie, Li, Jingjing, Dai, Weiqi, Xu, Xuanfu, Wu, Jianye, Zhou, Yingqun, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946110/ https://www.ncbi.nlm.nih.gov/pubmed/36843944 http://dx.doi.org/10.3389/fphar.2023.1081980 |
Ejemplares similares
-
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
por: Li, Yan, et al.
Publicado: (2023) -
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway
por: Yu, Qiang, et al.
Publicado: (2022) -
Cellular based immunotherapy for primary liver cancer
por: Zheng, Yuanyuan, et al.
Publicado: (2021) -
Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPARα Pathway
por: Jiang, Yuhui, et al.
Publicado: (2022) -
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
por: Feng, Jiao, et al.
Publicado: (2020)